Skip to content
Centrient Pharmaceuticals logo — Global B2B leader in sustainable, enzymatic antibiotics, nex...

Centrient Pharmaceuticals

Global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals

Founded 1869 The Netherlands The Netherlands 942 employees

General Information

Company Name Centrient Pharmaceuticals
Founded Year 1869
Location The Netherlands The Netherlands
Employees 942
Social

BounceWatch is an independent company data service, not affiliated with Centrient Pharmaceuticals. To contact Centrient Pharmaceuticals, visit centrient.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Centrient Pharmaceuticals compare?

A PDF of Centrient Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Centrient Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Centrient Pharmaceuticals

Centrient Pharmaceuticals is a global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins, and anti-fungals. The company produces and sells intermediates and active pharmaceutical ingredients (APIs), as well as its own tablets, capsules, and other finished dosage forms (FDFs). With a history dating back to 1869 as the ‘Nederlandsche Gist- en Spiritusfabriek’, the company has evolved through various names including Gist Brocades and DSM Sinochem Pharmaceuticals, and is currently headquartered in The Netherlands, with production facilities and sales offices across China, India, Spain, the United States, and Mexico. Centrient Pharmaceuticals, with over 1,800 employees, prides itself on its commitment to Quality, Reliability, and Sustainability at the core of its operations. Notably, the company actively participates in the fight against antimicrobial resistance, positioning itself at the center of modern healthcare as a maker of essential and life-saving medicines. Centrient Pharmaceuticals is Bain Capital Private Equity's portfolio company, a leading global private investment firm, which injects significant resources and expertise into the company’s growth and development. As a global market leader in its niche, Centrient Pharmaceuticals is well-positioned to capitalize on the increasing demand for sustainable pharmaceuticals. The company’s focus on sustainability and its extensive product portfolio make it an attractive investment opportunity for venture capitalists seeking to support innovative solutions in the pharmaceutical industry.

Business keywords: Pharmaceuticals, APIs, Antibiotics, Statins, Anti-fungals, Reliability, Sustainable Future, Antimicrobial Resistance, Global Leader, Enzymatic, Investment

No funding data available for Centrient Pharmaceuticals yet.

Centrient Pharmaceuticals Alternatives & Competitors

Centrient Pharmaceuticals vs

Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in t...

Debt Financing
4 employees
Biotechnology, Pharmaceutical
Centrient Pharmaceuticals vs
Qpex Biopharma
Qpex Biopharma United States

Focusing on Resistance in Antibiotic Development

Grant
29 employees
Biotechnology, Health Care
Centrient Pharmaceuticals vs
TOKU-E Company
TOKU-E Company United States

Makers of innovative antimicrobials to further your discoveries.

25 employees
Biotechnology, Manufacturing

FAQ About Centrient Pharmaceuticals

Global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals
Centrient Pharmaceuticals was founded in 1869.
Centrient Pharmaceuticals is headquartered in The Netherlands.
Centrient Pharmaceuticals has approximately 942 employees.
Top alternatives and competitors to Centrient Pharmaceuticals include Nosopharm, Qpex Biopharma, TOKU-E Company, Recce Pharmaceuticals Ltd, ENGEL. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Centrient Pharmaceuticals and Nosopharm are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Centrient Pharmaceuticals, https://bouncewatch.com/company/centrient-pharmaceuticals, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout